Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular verapamil for knee osteoarthritis pain
NCT01645709Phase 2Terminated
- Sponsor
- Calosyn Pharma
- Start
- Apr 2012
- Primary completion
- Feb 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of verapamil in knee osteoarthritis (OA), sponsored by Calosyn Pharma. Started Apr 2012; status: terminated.
02
Drugs
verapamil
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01645709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01645709.